Identifying Predictors Of Response To Mepolizumab In CRSwNP

Condition:   Chronic Rhinosinusitis With Nasal Polyps Intervention:   Drug: Mepolizumab 100 MG Injection Sponsor:   Centre hospitalier de l'Université de Montréal (CHUM) Not yet recruiting

Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials